← SynDRA
VELIFLAPON
SynDRA canonical compound SYN0003584 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ALOX5AP |
|---|
| Mechanism of action | leukotriene synthesis inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ALOX5AP INHIBITOR
- 5-lipoxygenase activating protein inhibitor
- leukotriene synthesis inhibitor
Cross-references
Synonyms
- BAY-X-1005
- BAY-X-005
- DG-031
- DG031
- BAY-X 1005
- DG 031
- Bayx-1005
- Bay-X1005
- UNII-JXH6X663L0
- BAY 1005
- CHEMBL88712
- JXH6X663L0
- 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid
- Benzeneacetic acid, alpha-cyclopentyl-4-(2-quinolinylmethoxy)-, (R)-
- C23H23NO3
- (2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid
- Veliflapon [USAN:INN]
- Velifapon
- Veliflapon (USAN/INN)
- AC1L3X6M
- MLS006010705
- Benzeneacetic acid, a-cyclopentyl-4-(2-quinolinylmethoxy)-,(aR)-
- GTPL5148
- veliflaponum
- RefChem:901779
- DTXCID4078334
- Bay X1005
- Veliflapon [USAN]
- ZEYYDOLCHFETHQ-JOCHJYFZSA-N
- QY1
- VELIFLAPON [INN]
- orb1708256
- SCHEMBL1004174
- SCHEMBL29405516
- DFA25331
- BDBM50052030
- EX-A14470
- AKOS024457673
- NCGC00250411-01
Look up VELIFLAPON in the interactive SynDRA portal →